Loading...
XNAS
LMRI
Market cap1.02bUSD
Oct 08, Last price  
10.33USD
1D
-2.46%
1Q
-13.92%
IPO
-44.25%
Name

Lumexa Imaging Holdings Inc

Chart & performance

D1W1MN
XNAS:LMRI chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
1.02b
+7.82%
935,925,000948,869,0001,023,081,000
Net income
-47m
L-49.94%
-122,227,000-94,099,000-47,104,000
CFO
17m
-58.08%
37,514,00040,727,00017,074,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.

Key people

J. Anthony Martin
Chief Financial Officer · since 2025
Henry Cooper
Executive Chairman of the Board · since 2024
Russell Stewart
Chief Medical Officer · since 2025
Julie Szeker
Chief Legal Officer and Corporate Secretary · since 2018
Robert Mittl
Director · since 2025
Caitlin Zulla
Chief Executive Officer, Director · since 2025
Brett Brodnax
Independent Director · since 2025
Glenn Eisenberg
Independent Director · since 2025
Lead Independent Director · since 2025
Bridget Karlin
Independent Director · since 2025
Matthew Lungren
Independent Director · since 2025
Brian Regan
Independent Director · since 2025
IPO date
Dec 11, 2025
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFY
2025‑122024‑122023‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT